Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04753320 · ClinicalTrials.gov registry record
Remote Monitoring in Progressive Supranuclear Palsy (PSP)
A clinical trial of Parkinson Disease and Progressive Supranuclear Palsy, sponsored by Massachusetts General Hospital.
- Active
- Registry status
- 85
- Enrollment target
- 2
- Study locations
NCT04753320 is a study of Parkinson Disease and Progressive Supranuclear Palsy that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 85 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT04753320, a study of Parkinson Disease and Progressive Supranuclear Palsy, is active but no longer recruiting, sponsored by Massachusetts General Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- 85 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a single-arm, longitudinal, observational study on the use of wearable sensors and digital health technology to measure fall frequency and motor, speech, and cognitive function in patients with PSP over the course of approximately one year. Participants will perform supervised remote assessments monthly and in-person assessments approximately every 6 months.
Conditions Studied
Study Locations (2)
Maryland
- Johns Hopkins - Baltimore
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2021-05-05 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04753320
The ClinicalTrials.gov registry entry for NCT04753320 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (98% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 0 interventions.
NCT04753320 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Maryland, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04753320 about?
NCT04753320 is a clinical study titled "Remote Monitoring in Progressive Supranuclear Palsy (PSP)". This is a single-arm, longitudinal, observational study on the use of wearable sensors and digital health technology to measure fall frequency and motor, speech, and cognitive function in patients with PSP over the course of approximately one year. Participants will perform supervised remote assessm...
What is the current status of trial NCT04753320?
This trial is currently active not recruiting. The enrollment target is 85 participants. The study started on 2021-05-05. Estimated completion is 2026-12.
What conditions does trial NCT04753320 study?
This clinical trial studies the following conditions: Parkinson Disease, Progressive Supranuclear Palsy, MSA - Multiple System Atrophy.
Who is sponsoring clinical trial NCT04753320?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04753320 being conducted?
This trial has 2 study locations across Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
RECRUITING · NA
-
Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis
RECRUITING
-
University of Delaware Parkinson's Disease Registry
RECRUITING
-
Neocortical Microarchitecture of Executive Function
RECRUITING · NA
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.